Take diabetes control to a whole new level

The Guardian® REAL-Time Continuous Glucose Monitoring System lets you keep a close eye on your glucose levels and how they change over the course of your day.
  • Improve your therapy and hypoglycaemia awareness.
  • Improve your REAL-life decisions through new insights on the impact of daily activities on your glucose control.
  • Benefit from our experience as the world leader in continuous glucose monitoring.

Improves therapy and hypoglycaemia awareness

The information generated by the Guardian REAL-Time System can give you unprecedented control over the way you manage your diabetes. Continuous glucose monitoring can reduce your A1C levels when compared with fingersticks alone[1, 2, 3, 4, 5], which in turn can reduce your risk of longterm health complications[5]. Research has shown that Guardian continuous glucose monitoring technology can help prevent or reduce the duration of hypoglycaemic occurences6 by making you more aware of approaching lows. Preventing hypoglycaemic occurrences can break the cycle of hypoglycaemia unawareness by restoring symptoms necessary for detection and prevention[7].

New insights, better decisions

In a pilot study (n = 16) of diabetes patients using Guardian continuous glucose monitoring technology[8]:
  • 94% used readings and/or alerts to control their glucose levels
  • 81% reported greater satisfaction with their glucose control
  • 75% adjusted their insulin delivery
  • 63% changed their diet
  • 31% made lifestyle changes
The world leader in continuous glucose monitoring
Almost a decade ago, Medtronic Diabetes conducted its first continuous glucose monitoring clinical study. Just a few years later, CGMS System, the world's first continuous glucose monitoring system, was approved by the FDA for use by doctors. Since then, Medtronic has become the industry leader in continuous glucose monitoring by introducing groundbreaking products to help more and more people with diabetes.

Our latest innovation, the Guardian REAL-Time System, is a highly advanced, personal continuous glucose monitoring system reflecting years of patient user experience.
Clinical references
  1. Kaufman FR, et al. Diabetes Care. 2001;24(12):2030-2034.
  2. Ludvigsson J, et al. Pediatrics. 2003;111(5 pt 1):933-938.
  3. Deiss D, et al. Diabetes Care. 2006; 29(12):2730-2732.
  4. Bode BW, et al. Diabetes Res Clin Pract. 1999;46(3):183-190.
  5. American Diabetes Association. Diabetes Care. 2002;25(1):213-229.
  6. Bode B, et al. Diabetes Technol Ther. 2004;6(2):105-113.
  7. Fanelli C, et al. Diabetes. 1997;36(7):1172-1181.
  8. Deiss D, et al. Diabetes, 2005; 54 (suppl 1): 393-P.
Copyright © 2008 Medtronic MiniMed, Inc.Terms of use | Privacy statement | Media | Contact Medtronic Diabetes